Bristol-Myers Squibb (United Kingdom)

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Solubility parameters as predictors of miscibility in solid dispersions

David J. Greenhalgh, Adrian C. Williams, Peter Timmins et al. · Journal of Pharmaceutical Sciences · 1999 · 655 citations

ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi

William Gattrell, Patrícia Logullo, Esther J van Zuuren et al. · PLoS Medicine · 2024 · 407 citations · Full text

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

Padmanee Sharma, Russell K. Pachynski, Vivek Narayan et al. · Cancer Cell · 2020 · 371 citations

Urology, Oncology, Nivolumab Plus Ipilimumab +8

Nickel‐Catalyzed Barton Decarboxylation and Giese Reactions: A Practical Take on Classic Transforms

Tian Qin, Lara R. Malins, Jacob T. Edwards et al. · Angewandte Chemie International Edition · 2016 · 299 citations · Full text